128 related articles for article (PubMed ID: 11855677)
21. 16,16-Dimethyl prostaglandin E2 protects gastric mucosal surface epithelial cells from indomethacin-induced damage in rats.
Ohno T; Yamamoto K; Takeuchi K; Okabe S
Jpn J Pharmacol; 1987 Feb; 43(2):213-20. PubMed ID: 3573426
[TBL] [Abstract][Full Text] [Related]
22. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats.
Suzuki K; Araki H; Komoike Y; Takeuchi K
Med Sci Monit; 2000; 6(5):908-14. PubMed ID: 11208431
[TBL] [Abstract][Full Text] [Related]
23. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
Yokota A; Taniguchi M; Tanaka A; Takeuchi K
Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
[TBL] [Abstract][Full Text] [Related]
24. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats.
Takeuchi K; Abe N; Kumano A
Curr Neuropharmacol; 2016; 14(8):866-875. PubMed ID: 27397599
[TBL] [Abstract][Full Text] [Related]
25. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Ohno R; Yokota A
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
Nishio H; Hayashi Y; Terashima S; Takeuchi K
Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
[TBL] [Abstract][Full Text] [Related]
27. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
29. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
30. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
31. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
[TBL] [Abstract][Full Text] [Related]
32. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K
Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
35. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
36. Preventive effect of atropine on indomethacin-induced gastrointestinal mucosal and vascular damage in rats.
Karádi O; Abdel-Salam OM; Bódis B; Mózsik G
Pharmacology; 1996 Jan; 52(1):46-55. PubMed ID: 8966202
[TBL] [Abstract][Full Text] [Related]
37. Gastric surface epithelial cell damage induced by restraint and water-immersion stress in rats. Protective effects of 16,16-dimethyl-prostaglandin E2.
Ohno T; Okabe S
J Clin Gastroenterol; 1988; 10 Suppl 1():S46-52. PubMed ID: 3183342
[TBL] [Abstract][Full Text] [Related]
38. Atropine-induced gastrointestinal cytoprotection dependences to the intact of vagal nerve against indomethacin-induced gastrointestinal mucosal and microvascular damage in rats.
Karádi O; Nagy Z; Bódis B; Mózsik G
J Physiol Paris; 2001; 95(1-6):29-33. PubMed ID: 11595415
[TBL] [Abstract][Full Text] [Related]
39. Surface epithelial cell damage induced by restraint and water-immersion stress in rats effects of 16,16-dimethyl prostaglandin E2 on stress-induced gastric lesions.
Ohno T; Hirose N; Uramoto H; Ishihara T; Okabe S
Jpn J Pharmacol; 1987 Nov; 45(3):405-15. PubMed ID: 3437604
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression.
Kato S; Nishio H; Ogura M; Takeuchi K
J Pharmacol Sci; 2007 Jan; 103(1):40-7. PubMed ID: 17202747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
